Naphalon Ophthalmic Solution Eye Drop 0.005%+0.02% is a Product of the Generic Naphazoline + Zinc Sulfate

What Is Naphalon Ophthalmic Solution Eye Drop 0.005%+0.02% Indications and Uses?

This ophthalmic solution is indicated in- Acute and chronic non-infectious conjunctivitis, nonspecific conjunctival irritation; also after successful treatment of bacterial and viral conjunctivitis. Irrigation of the tear ducts.

Pharmacology (Source, Chemical and Physical Composition) Of Naphalon Ophthalmic Solution Eye Drop 0.005%+0.02%

Zinc ions, the active compound of zinc sulphate, have an astringent, i.e. tissue-sealing and slightly anti-septic effect. Naphalon Ophthalmic Solution Eye Drop 0.005%+0.02% (Naphazoline + Zinc Sulfate) constricts the blood vessels and reduces the inflammation and swelling of the conjunctiva. This effect of naphazoline, a substance of the benzylimidazoline group, is due to direct binding to a-adrenergic receptor sites on unstriated muscle cells in the blood vessels.

Dosage And Administration of Naphalon Ophthalmic Solution Eye Drop 0.005%+0.02%

Adults : One drop in the conjunctival sac, three to four times per day. Children : This eye drop has not been studied in children. Generally, in children the dosage of vasoconstrictors should be low and selected with caution.

Drug Interactions of Naphalon Ophthalmic Solution Eye Drop 0.005%+0.02%

Naphalon Ophthalmic Solution Eye Drop 0.005%+0.02% (Naphazoline + Zinc Sulfate) containing products should not be administered during treatment with MAO-blockers nor during 10 days after discontinuation of such treatment. The effects of Naphazoline may be increased by concomitant use of tricyclic antidepressants.

Side Effects of Naphalon Ophthalmic Solution Eye Drop 0.005%+0.02%

Mydriasis and a slight increase of intraocular pressure in isolated cases. A slight and transient burning sensation may occur after instillation, which does not affect the success of the treatment. Long term use may result in reactive redness of the eye (rebound effect). Systemic effects: In very rare cases systemic cardiovascular effects, such as hypertension and arrhythmia, may occur. Nonspecific fatigue has been observed in some patients.

Precautions And Warnings for Naphalon Ophthalmic Solution Eye Drop 0.005%+0.02%

Uncontrolled use of Naphalon Ophthalmic Solution Eye Drop 0.005%+0.02% (Naphazoline + Zinc Sulfate) & Zinc over extended periods of time should be avoided. If no improvement is seen after 2 days, treatment should be discontinued and other therapeutic measures should be considered. If ocular discomfort or visual disturbance occurs during Naphazoline & Zinc treatment, the therapy must be discontinued. Caution is indicated in patients with predisposition to glaucoma and in patients suffering from hypertension, cardiovascular diseases, pheochromocytoma, aneurysm, hyperglycemia, and hyperthyroidism.

Use During Pregnancy and Lactation

Pregnancy category C. There are neither controlled animal studies nor studies in pregnant women available.Therefore,during pregnancy the product should only be used if the benefit out-weighs the risk to the fetus. The effects of Naphalon Ophthalmic Solution Eye Drop 0.005%+0.02% (Naphazoline + Zinc Sulfate) & Zinc Sulphate treatment during lactation has not been investigated.

Therapeutic Class

Ophthalmic Non-Steroid drugs

Storage Conditions of It

Store in a cool,dry place and away from light. Do not use longer than 30 days after first opening. Keep out of the reach of children. Thanks for using MedEx! How would you rate your experience so far?